ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
102 hedge funds and large institutions have $67.5M invested in Endocyte, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $74.3M → $67.5M (-$6.82M)
Holders
102
Holding in Top 10
–
Calls
$401K
Puts
$407K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$916K | |
| 3 | +$527K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$466K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$376K |
Top Sellers
| 1 | -$428K | |
| 2 | -$392K | |
| 3 | -$284K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$266K |
| 5 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$233K |